openPR Logo
Press release

Monoclonal Antibodies market - industry analysis, growth, size, manufacturers, and forecast

11-22-2017 10:21 AM CET | Health & Medicine

Press release from: Reports Monitor

Monoclonal Antibodies manufacturers market report

Monoclonal Antibodies manufacturers market report

Monoclonal Antibodies Market

Description:

Reports Monitor Publish a New Market Research Report on – “Monoclonal Antibodies – Global Trends in the Competitive, Technological and R&D Landscape”.

Latest report, "Monoclonal Antibodies Market- Global Trends in the Competitive, Technological and R&D Landscape" discusses both the pipeline and market shares of monoclonal antibodies (mAbs) across a number of therapy areas. mAbs are defined as a collection of antibodies produced from a single B-cell clone. These antibodies therefore share binding specificity towards a certain antigen, and can be used as a means of targeted therapy within a number of indications across the pharmaceutical market.
mAbs have been in development in humans since the mid-1970s, and a substantial number of mAb products have entered the market. However, the majority are still in early-stage development, indicating delays and setbacks in the progression of potential products. Despite this, mAbs are the largest and fastest-growing segment of the biopharmaceutical sector, and account for almost half of the global revenue accrued from this area annually.
The pipeline is highly active, with 2,836 mAbs currently in development. Most are at an early stage of development, with 76% at the Discovery or Preclinical stage. Additionally, there are currently 85 mAb programs in Phase III development, and 22 at the Pre-registration stage, accounting for just under 4% of the total mAb pipeline.

Request a sample copy of Monoclonal Antibodies market report@ https://www.reportsmonitor.com/request-sample/?post=442400

Scope
- While many mAbs that enter the market achieve commercial success, a large proportion are stuck at early-stage development:
- What strategies can be put in place to advance the production of mAbs?
- What strategies can be used to improve both the affinity and therapeutic efficacy of mAbs?
- What are the relative advantages and disadvantages of each mAb type, and which hold the most promise?



Key Reasons to Purchase
- Understand the current status of the field of therapeutic mAbs, and the relative clinical and commercial success of currently marketed products, comprising Humira, Remicade, Rituxan, Avastin, Herceptin, Opdivo, Lucentis, Stelara and Soliris
- Assess the pipeline for mAbs split by therapy area, mAb type, and stage of development. Additionally, a granular assessment of the pipeline is provided across the four most active therapy areas for mAbs: oncology, infectious diseases, immunology and central nervous system disorders

Make an Enquiry of Monoclonal Antibodies market report@ https://www.reportsmonitor.com/make-enquiry/?post=442400

Table of Contents

Overview of mAbs 4
2.1 Initial mAb Development 6
2.2 Transition to Therapeutics 6
2.3 Present-Day Clinical and Research Applications 7
2.4 Commercial Progress within the mAb Market 8
3 Manufacture and Mechanism of mAbs 10
3.1 Classification of mAbs 10
3.1.1 By Type 10
3.1.2 By Target Specificity 11
3.1.3 By Mechanism of Action 13
3.2 Production of mAbs 15
3.2.1 Hybridomas 15
3.2.2 Phage Libraries/Phage Display 17
3.2.3 Transgenic Animals 18
3.3 Challenges in the mAb Market 18
3.3.1 Strategies for Improving mAb Efficacy 18
3.3.2 Biosimilars and Biobetters 21
4 Major mAb-Targeting Therapy Areas 23
4.1 Anti-Cancer 23
4.2 Anti-Inflammatory/Autoimmune 25
5 Key Marketed mAb Products 27

Continued...

Browse Detailed TOC, Tables, Figures, Charts and Companies Mentioned in Monoclonal Antibodies Market Research Report @ https://www.reportsmonitor.com/monoclonal-antibodies-global-trends-in-the-competitive-technological-and-rd-landscape/

In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

About us
We at Reports Monitor provide a comprehensive analysis by providing in-depth reports of the various market verticals. Our Mission is providing a detailed analysis of the vast markets worldwide, backed by rich data. Decision makers can now rely on our well-defined data gathering methods to get the correct and accurate market forecasting along with detailed analysis.

Contact us
Jay Matthews
Direct: +1 513 549-5911
Email: sales@reportsmonitor.com
Website: www.reportsmonitor.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Monoclonal Antibodies market - industry analysis, growth, size, manufacturers, and forecast here

News-ID: 827882 • Views: 98

More Releases from Reports Monitor

2019 Global Smart Home Security and Safety Systems Market Trend Analysis and Ind …
Smart Home Security and Safety Systems Market GMD analysis model indicates that the aggregated revenue of global smart home security & safety systems market during 2019-2025 is expected to reach $134.5 billion owing to growing adoption of various types of smart security devices in global households. Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below:- www.reportsmonitor.com/request_sample/352365 Scope of the Report: Highlighted with 72
Radar Sensor Market 2019 Top Key Players: NXP Semiconductors N.V., Robert Bosch …
Radar Sensor Market The report provides a global analysis of Radar Sensor Market data from 2019 to 2024. The report reveals the overview, chain structure, and illustrate the industry’s current situation, evaluate global market volume/share. The market report studies key player’s Profiles/Analysis, product insights, regional analysis insights, product types, and product application insights. The market has been qualified based on a comprehensive market analysis with inputs from industry experts. Have Questions?
OKR Software Market report with Leading players: SpiraLinks, Wrike, BetterWorks, …
2019-2025 OKR Software Market Report with Depth Analysis: The report provides a global analysis of the OKR Software Market report provides Insightful information to the clients enhancing their basic leadership capacity identified. This Report is segmented into Manufactures, Types, Applications, and Regions. The market covers the wide spectrum of the factors governing future growth, including drivers, challenges, emerging trends, technology changes, and environmental factors. The global OKR Software market size was xx million US$
Event Logistics Market analysis report with Major players Rhenus Logistics, UPS, …
Event Logistics Market Market Overview of Event Logistics Market: The report provides a global analysis of Event Logistics Market Report provides Insightful information to the clients enhancing their basic leadership capacity identified. This Report is segmented into Manufactures, Types, Applications, and Regions. The market covers the wide spectrum of the factors governing future growth including drivers, challenges, emerging trends, technology changes, and environmental factors. The global Event Logistics market size was xx

All 5 Releases


More Releases for Monoclonal

Global Cancer Monoclonal Antibodies Market &Clinical Trial Insight 2024
" Global Cancer Monoclonal Antibodies Market &Clinical Trial Insight 2024" Report Highlights: * Significance for Monoclonal Antibodies for Cancer Treatment * Global Cancer Monoclonal Antibodies Market Overview * Global Cancer Monoclonal Antibodies Pipeline by Phase & Indication * Global Cancer Monoclonal Antibodies Pipeline: 697 mAb * Marketed Cancer Monoclonal Antibodies: 60 * Global Cancer Monoclonal Antibodies Market Opportunity: US$ 140 Billion The recent years have witnessed the emergence of monoclonal antibodies, which has the potential
Monoclonal Antibodies market In Depth overview by Experts 2018
The Monoclonal Antibodies market outlook of the global industry is provided based on the Monoclonal Antibodies growth drivers, constraints and threats, SWOT analysis, and Monoclonal Antibodies market share study. The drivers and constraints of Monoclonal Antibodies industry recognize the rise and fall of the Monoclonal Antibodies market. The study is served based on the Monoclonal Antibodies haggling power of buyers, haggling power of suppliers, the risk of new entrants, the
Monoclonal Antibody Custom Service Market Ravishing Growth with CAGR of 10.84% | …
Complete Study of Monoclonal Antibody Custom Service Market Research Report is added on MarketResearchFuture.com with Latest Advancement. Detail analysis on possible segments and sub segments of the market. Along with this regional analysis of the market which includes North America, Europe, Asia Pacific and Middle East and Africa. Avail Premium Sample Copy @ https://www.marketresearchfuture.com/sample_request/4515 Monoclonal Antibody Custom Service Market – Overview It is estimated that monoclonal antibody custom service market is expected to
Global Monoclonal Antibodies Pipeline Analysis
The market for monoclonal antibodies (mAB) has become the fastest growing segment of the pharmaceutical industry. In 2012, there were more than 30 monoclonal antibody therapies approved by the FDA which generated annual sales of more than US$ 40 Billion. As the therapeutic mABs already play a significant part in effective medical treatment, it is most likely that their importance would increase by manyfolds in the future. There has been a
Global Cancer Monoclonal Antibodies Pipeline Analysis
In the past few years monoclonal antibodies have emerged as a therapeutic modality for cancer. These monoclonal antibodies are designed to selectively target cancer cells and extract various responses, thus indirectly protecting the non cancerous cells. This characteristic of monoclonal antibodies coupled with increasing potential of the oncology market has made many pharmaceutical giants to invest a significant portion of their R&D on cancer monoclonal antibodies. In recent years the popularity
Global Monoclonal Antibodies Pipeline Insight 2015
Ever since the Nobel Prize was bestowed on the person who invented the technology which enabled the preparation of monoclonal antibodies in 1984, their use has considerably expanded far beyond the scientific realm. Paul Ehrlich framed a hypothesis that a “magic bullet” could be developed with an objective of targeting selective diseases. With the introduction and development of hybridoma technology by Kohler and Milstein, this hypothesis has become a reality.